Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994;40(5):319-24.
doi: 10.1007/BF01246672.

The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia

Affiliations

The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia

J Rohrer et al. Immunogenetics. 1994.

Erratum in

  • Immunogenetics 1995;42(1):76

Abstract

It has recently been demonstrated that mutations in the gene for Bruton's tyrosine kinase (BTK) are responsible for X-linked agammaglobulinemia. Southern blot analysis and sequencing of cDNA were used to document deletions, insertions, and single base pair substitutions. To facilitate analysis of BTK regulation and to permit the development of assays that could be used to screen genomic DNA for mutations in BTK, we determined the genomic organization of this gene. Subcloning of a cosmid and a yeast artificial chromosome showed that BTK is divided into 19 exons spanning 37 kilobases of genomic DNA. Analysis of the region 5' to the first untranslated exon revealed no consensus TATAA or CAAT boxes; however, three retinoic acid binding sites were identified in this region. Comparison of the structure of BTK with that of other nonreceptor tyrosine kinases, including SRC, FES, and CSK, demonstrated a lack of conservation of exon borders. Information obtained in this study will contribute to our understanding of the evolution of nonreceptor tyrosine kinases. It will also be useful in diagnostic studies, including carrier detection, and in studies directed towards gene therapy or gene replacement.

PubMed Disclaimer

References

    1. Hum Mol Genet. 1993 Feb;2(2):139-41 - PubMed
    1. Oncogene. 1993 May;8(5):1365-9 - PubMed
    1. Annu Rev Biochem. 1986;55:1119-50 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11194-8 - PubMed
    1. J Immunol. 1994 Jan 15;152(2):557-65 - PubMed

Publication types

Substances

LinkOut - more resources